Publication | Closed Access

Drug cost avoidance resulting from cancer clinical trials

OncologyHealth EconomicsClinical TrialsPharmacoeconomicsCost EffectivenessDrug TrialMedicineDrug Cost AvoidanceCancer ResearchHealth Sciences